Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden
This study suggests that BRCA1/2 pathogenic variants do not independently impact survival outcomes in HR-negative BC. However, a moderate association between BRCA status and OS cannot be ruled out.
Authors
- Toshima Z. Parris (ORCID: https://orcid.org/0000-0003-0834-5540)
- Anna-Karin Tzikas (ORCID: https://orcid.org/0000-0003-2183-7734)
- Anikó Kovács (ORCID: https://orcid.org/0000-0001-7711-4418)
- Lovisa Lovmar
- Erik Holmberg (ORCID: https://orcid.org/0000-0001-5107-4550)
- Per Karlsson (ORCID: https://orcid.org/0000-0003-4841-2672)
Institutions
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- NU Hospital Group (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-04-16
- DOI
- https://doi.org/10.2340/1651-226x.2025.43109
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancerfonden
- Vetenskapsrådet
- Göteborgs Universitet